Mirae Asset Global ETFs Holdings
OPRX icon

Mirae Asset Global ETFs Holdings’s OptimizeRx OPRX Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio OPRX Stock Details OPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-7,526
Closed -$47.3K – 3285
2026
Q1 		$47.3K Buy
7,526
+170
+2% +$1.58K ﹤0.01% 2917
2025
Q4 		$90.2K Buy
7,356
+126
+2% +$2.06K ﹤0.01% 2721
2025
Q3 		$148K Sell
7,230
-2,332
-24% -$37K ﹤0.01% 2476
2025
Q2 		$129K Sell
9,562
-1,098
-10% -$12K ﹤0.01% 2478
2025
Q1 		$92.3K Buy
10,660
+468
+5% +$2.86K ﹤0.01% 2670
2024
Q4 		$49.5K Buy
10,192
+456
+5% +$2.55K ﹤0.01% 2904
2024
Q3 		$75.2K Buy
9,736
+1,601
+20% +$14.2K ﹤0.01% 2817
2024
Q2 		$81.3K Buy
+8,135
New +$89.4K ﹤0.01% 2643

Other funds holding OPRX

WCA
Whetstone Capital Advisors Shawnee Mission, Kansas $380M AUM 20.01% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
KCM
Kennedy Capital Management St Louis, Missouri $5.65B AUM 61.31% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PHP
Parkman Healthcare Partners Stamford, Connecticut $977M AUM 110.37% 1-Year Est. Return

Mirae Asset Global ETFs Holdings's OPRX Position: Q2 2026 in Review

Mirae Asset Global ETFs Holdings sold out of OptimizeRx (OPRX) in Q2 2026, closing a stake of 7,526 shares — an estimated $47.3K sold.

Mirae Asset Global ETFs Holdings first reported a position in OPRX in Q2 2024 and held it in 8 quarters. The position peaked at $148K in Q3 2025. 112 funds tracked by Wall St. Rank hold OPRX as of Q2 2026.

  • Mirae Asset Global ETFs Holdings reported no remaining OptimizeRx position as of Q2 2026 after selling out during the quarter.
  • Mirae Asset Global ETFs Holdings sold 7,526 OptimizeRx shares in Q2 2026, an estimated $47.3K.
  • Mirae Asset Global ETFs Holdings first reported a position in OptimizeRx in Q2 2024 and held it in 8 quarters.
  • Mirae Asset Global ETFs Holdings's OptimizeRx position peaked at $148K in Q3 2025.
  • 112 funds tracked by Wall St. Rank held OptimizeRx as of Q2 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.